Abstract
[...]clinical validation requires a gold standard (a reliable clinical phenotype), which, as of yet, does not exist for autoimmune retinopathy. [...]it will be difficult to validate ARA testing without a consensus on clinical diagnosis and a standardized approach to ARA testing.
